Authors:
Gao, CQ
Giri, M
Van Hoecke, MJ
Mertens, K
Van Den Saffele, J
Kaufman, JM
Citation: Cq. Gao et al., Marked species specificity of guinea pig luteinizing hormone: Validation of a bioassay, J ANDROLOGY, 22(2), 2001, pp. 226-234
Authors:
Christophe, OD
Lenting, PJ
Cherel, G
Boon-Spijker, M
Lavergne, JM
Boertjes, R
Briquel, ME
de Goede-Bolder, A
Goudemand, J
Gaillard, S
d'Oiron, R
Meyer, D
Mertens, K
Citation: Od. Christophe et al., Functional mapping of anti-factor IX inhibitors developed in patients withsevere hemophilia B, BLOOD, 98(5), 2001, pp. 1416-1423
Authors:
van den Brink, EN
Turenhout, EAM
Bovenschen, N
Heijnen, BGADH
Mertens, K
Peters, M
Voorberg, J
Citation: En. Van Den Brink et al., Multiple VH genes are used to assemble human antibodies directed toward the A3-Cl domains of factor VIII, BLOOD, 97(4), 2001, pp. 966-972
Citation: Ja. Kolkman et K. Mertens, Surface-loop residue Lys(316) in blood coagulation Factor IX is a major determinant for Factor X but not antithrombin recognition, BIOCHEM J, 350, 2000, pp. 701-707
Citation: Phn. Celie et al., Hydrophobic contact between the two epidermal growth factor-like domains of blood coagulation factor IX contributes to enzymatic activity, J BIOL CHEM, 275(1), 2000, pp. 229-234
Authors:
Neels, JG
van den Berg, BMM
Mertens, K
ter Maat, H
Pannekoek, H
van Zonneveld, AJ
Lenting, PJ
Citation: Jg. Neels et al., Activation of factor IX zymogen results in exposure of a binding site for low-density lipoprotein receptor-related protein, BLOOD, 96(10), 2000, pp. 3459-3465
Citation: Ja. Kolkman et K. Mertens, Insertion loop 256-268 in coagulation factor IX restricts enzymatic activity in the absence but not in the presence of factor VIII, BIOCHEM, 39(25), 2000, pp. 7398-7405
Authors:
Mertens, K
Celie, PHN
Kolkman, JA
Lenting, PJ
Citation: K. Mertens et al., Factor VIII-factor IX interactions: Molecular sites involved in enzyme-cofactor complex assembly, THROMB HAEM, 82(2), 1999, pp. 209-217
Authors:
White, GC
DiMichele, D
Mertens, K
Negrier, C
Peake, IR
Prowse, C
Schwaab, R
Yoshioka, A
Ingerslev, J
Citation: Gc. White et al., Utilization of previously treated patients (PTPs), noninfected patients (NIPs), and previously untreated patients (PUPs) in the evaluation of new factor VIII and factor IX concentrates - Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and StandardizationCommittee of the International Society on Thrombosis and Haemostasis, THROMB HAEM, 81(3), 1999, pp. 462-462
Citation: Ja. Kolkman et al., Regions 301-303 and 333-339 in the catalytic domain of blood coagulation Factor IX are Factor VIII-interactive sites involved in stimulation of enzyme activity, BIOCHEM J, 339, 1999, pp. 217-221
Authors:
Szuwart, T
Zhao, B
Fritsch, A
Mertens, K
Dierichs, R
Citation: T. Szuwart et al., Oxidized low-density lipoprotein inhibits the binding of monoclonal antibody to platelet glycoprotein IIb-IIIa, THROMB RES, 96(2), 1999, pp. 85-90
Authors:
Kolkman, JA
Christophe, OD
Lenting, PJ
Mertens, K
Citation: Ja. Kolkman et al., Surface loop 199-204 in blood coagulation factor IX is a cofactor-dependent site involved in macromolecular substrate interaction, J BIOL CHEM, 274(41), 1999, pp. 29087-29093
Authors:
Lenting, PJ
Neels, JG
van den Berg, BMM
Clijsters, PPFM
Meijerman, DWE
Pannekoek, H
van Mourik, JA
Mertens, K
van Zonneveld, AJ
Citation: Pj. Lenting et al., The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein, J BIOL CHEM, 274(34), 1999, pp. 23734-23739
Authors:
Celie, PHN
van Stempvoort, G
Jorieux, S
Mazurier, C
van Mourik, JA
Mertens, K
Citation: Phn. Celie et al., Substitution of Arg(527) and Arg(531) in factor VIII associated with mild haemophilia A: characterization in terms of subunit interaction and cofactor function, BR J HAEM, 106(3), 1999, pp. 792-800